<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/DM2014390-95</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-6440</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Кардиология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Cardiology</subject></subj-group></article-categories><title-group><article-title>Прогностическое значение содержания адипоцитокинов у пациентов с инфарктом миокарда и различными вариантами нарушений углеводного обмена</article-title><trans-title-group xml:lang="en"><trans-title>Prognostic value of adipokines in patients with myocardial infarction and glucose metabolism disorders</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Холматова</surname><given-names>Камила Кахрамонжоновна</given-names></name><name name-style="western" xml:lang="en"><surname>Kholmatova</surname><given-names>Kamila Kahramonzhonovna</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, ассистент кафедры терапии, эндокринологии и скорой медицинской помощи</p></bio><bio xml:lang="en"><p>MD, PhD, Teaching Assistant at the Department of Internal Medicine, Endocrinology and Emergency Care</p></bio><email xlink:type="simple">kkholmatova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дворяшина</surname><given-names>Ирина Владимировна</given-names></name><name name-style="western" xml:lang="en"><surname>Dvoryashina</surname><given-names>Irina Vladimirovna</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор, заведующая кафедрой терапии, эндокринологии и скорой медицинской помощи</p></bio><bio xml:lang="en"><p>MD, PhD, Professor, Head of the Department of Internal Medicine, Endocrinology and Emergency Care</p></bio><email xlink:type="simple">dvoryashinva@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фомкина</surname><given-names>Ирина Адольфовна</given-names></name><name name-style="western" xml:lang="en"><surname>Fomkina</surname><given-names>Irina Adolfovna</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент кафедры семейной медицины и внутренних болезней</p></bio><bio xml:lang="en"><p>MD, PhD, Teaching Assistant at the Department of Family Medicine and Internal Diseases</p></bio><email xlink:type="simple">mojprizrak@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Супрядкина</surname><given-names>Татьяна Вячеславовна</given-names></name><name name-style="western" xml:lang="en"><surname>Supryadkina</surname><given-names>Tatiana Vyacheslavovna</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, ассистент кафедры терапии, эндокринологии и скорой медицинской помощи</p></bio><bio xml:lang="en"><p>MD, PhD, Teaching Assistant at the Department of Internal Medicine, Endocrinology and Emergency Care</p></bio><email xlink:type="simple">suprt@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБОУ ВПО Северный государственный медицинский университет, Архангельск</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Northern State Medical University, Arkhangelsk</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>01</day><month>07</month><year>2014</year></pub-date><volume>17</volume><issue>3</issue><fpage>90</fpage><lpage>95</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Холматова К.К., Дворяшина И.В., Фомкина И.А., Супрядкина Т.В., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Холматова К.К., Дворяшина И.В., Фомкина И.А., Супрядкина Т.В.</copyright-holder><copyright-holder xml:lang="en">Kholmatova K.K., Dvoryashina I.V., Fomkina I.A., Supryadkina T.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/6440">https://www.dia-endojournals.ru/jour/article/view/6440</self-uri><abstract/><trans-abstract xml:lang="en"/><kwd-group xml:lang="ru"><kwd>сахарный диабет</kwd><kwd>лептин</kwd><kwd>адипонектин</kwd><kwd>инфаркт миокарда</kwd><kwd>прогноз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>diabetes mellitus</kwd><kwd>leptin adiponectin</kwd><kwd>myocardial infarction</kwd><kwd>prognosis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">ГБОУ ВПО Северный государственный медицинский университет Министерства здравоохранения Российской Федерации, г. Архангельск</funding-statement><funding-statement xml:lang="en">Northern State Medical University, Arkhangelsk, Russian Federation</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Franklin K, Goldberg RJ, Spencer F, Klein W, Budaj A, Brieger D, Marre M, Steg PG, Gowda N, Gore JM; GRACE Investigators. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med. 2004;164(13):1457-1463. doi:10.1001/archinte.164.13.1457</mixed-citation><mixed-citation xml:lang="en">Franklin K, Goldberg RJ, Spencer F, Klein W, Budaj A, Brieger D, Marre M, Steg PG, Gowda N, Gore JM; GRACE Investigators. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med. 2004;164(13):1457-1463. doi:10.1001/archinte.164.13.1457</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Пальцева ЕМ, Родина АВ, Константинова СВ, Ермаков НВ, Андреев ДА, Сыркин АЛ, Северин СЕ. Прогностические, диагностические и терапевтические перспективы применения адипонектина в качестве биомаркера при сердечно-сосудистых заболеваниях. Российский физиологический журнал им. И.М. Сеченова. 2009;95(10):1024-1040. [Paltsev AM, Rodina AV, Konstantinova SV, Ermakov NV, Andreev DA, Syrkin AL, Severin SE. Prognostiс, diagnostiс and therapeutic prospects of using adiponectine as a biomarker in cardiobascular diseases. Fiziologičeskij Žurnal imeni I.M. Sečenova. 2009;95(10):1024-1040.]</mixed-citation><mixed-citation xml:lang="en">Пальцева ЕМ, Родина АВ, Константинова СВ, Ермаков НВ, Андреев ДА, Сыркин АЛ, Северин СЕ. Прогностические, диагностические и терапевтические перспективы применения адипонектина в качестве биомаркера при сердечно-сосудистых заболеваниях. Российский физиологический журнал им. И.М. Сеченова. 2009;95(10):1024-1040. [Paltsev AM, Rodina AV, Konstantinova SV, Ermakov NV, Andreev DA, Syrkin AL, Severin SE. Prognostiс, diagnostiс and therapeutic prospects of using adiponectine as a biomarker in cardiobascular diseases. Fiziologičeskij Žurnal imeni I.M. Sečenova. 2009;95(10):1024-1040.]</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Чубриева СЮ, Глухов НВ, Зайчик АМ. Жировая ткань как эндокринный регулятор (обзор литературы). Вестник Санкт-Петербургского Университета. Серия 11: Медицина. 2008;(1):32-44. [Tchoubrieva SYu, Gloukhov NV, Zaichik AM. Adipose tissue as an endocrine organ (Review of literature). Vestnik Sankt-Peterburgskogo universiteta. Serii︠a︡ 11, Medit︠s︡ina. 2008;(1):32-44.]</mixed-citation><mixed-citation xml:lang="en">Чубриева СЮ, Глухов НВ, Зайчик АМ. Жировая ткань как эндокринный регулятор (обзор литературы). Вестник Санкт-Петербургского Университета. Серия 11: Медицина. 2008;(1):32-44. [Tchoubrieva SYu, Gloukhov NV, Zaichik AM. Adipose tissue as an endocrine organ (Review of literature). Vestnik Sankt-Peterburgskogo universiteta. Serii︠a︡ 11, Medit︠s︡ina. 2008;(1):32-44.]</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Huang SS, Huang PH, Chen YH, Chiang KH, Chen JW, Lin SJ. Association of adiponectin with future cardiovascular events in patients after acute myocardial infarction. J Atheroscler Thromb. 2010;17(3):295-303. doi: 10.5551/jat.3533</mixed-citation><mixed-citation xml:lang="en">Huang SS, Huang PH, Chen YH, Chiang KH, Chen JW, Lin SJ. Association of adiponectin with future cardiovascular events in patients after acute myocardial infarction. J Atheroscler Thromb. 2010;17(3):295-303. doi: 10.5551/jat.3533</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Piestrzeniewicz K, Luczak K, Maciejewski M, Drozdz J. Low adiponectin blood concentration predicts left ventricular remodeling after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Cardiol J. 2010;17(1):49-56. PMid:20104457</mixed-citation><mixed-citation xml:lang="en">Piestrzeniewicz K, Luczak K, Maciejewski M, Drozdz J. Low adiponectin blood concentration predicts left ventricular remodeling after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Cardiol J. 2010;17(1):49-56. PMid:20104457</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Persson J, Lindberg K, Gustafsson TP, Eriksson P, Paulsson-Berne G, Lundman P. Low plasma adiponectin concentration is associated with myocardial infarction in young individuals. J Intern Med. 2010;268(2):194-205. doi: 10.1111/j.1365-2796.2010.02247.x</mixed-citation><mixed-citation xml:lang="en">Persson J, Lindberg K, Gustafsson TP, Eriksson P, Paulsson-Berne G, Lundman P. Low plasma adiponectin concentration is associated with myocardial infarction in young individuals. J Intern Med. 2010;268(2):194-205. doi: 10.1111/j.1365-2796.2010.02247.x</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J. 2006;27(19):2300-2309. doi: 10.1093/eurheartj/ehl153</mixed-citation><mixed-citation xml:lang="en">Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J. 2006;27(19):2300-2309. doi: 10.1093/eurheartj/ehl153</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lindberg S, Pedersen SH, Møgelvang R, Bjerre M, Frystyk J, Flyvbjerg A, et al. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol. 2012;109(4):492-496. doi: 10.1016/j.amjcard.2011.09.041</mixed-citation><mixed-citation xml:lang="en">Lindberg S, Pedersen SH, Møgelvang R, Bjerre M, Frystyk J, Flyvbjerg A, et al. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol. 2012;109(4):492-496. doi: 10.1016/j.amjcard.2011.09.041</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Söderberg S, Colquhoun D, Keech A, Yallop J, Barnes EH, Pollicino C, et al. Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study. Int J Obes (Lond). 2009;33(1):123-130. doi: 10.1038/ijo.2008.224</mixed-citation><mixed-citation xml:lang="en">Söderberg S, Colquhoun D, Keech A, Yallop J, Barnes EH, Pollicino C, et al. Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study. Int J Obes (Lond). 2009;33(1):123-130. doi: 10.1038/ijo.2008.224</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wolk R, Berger P, Lennon RJ, Brilakis ES, Johnson BD, Somers VK. Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol. 2004;44(9):1819-1824. doi: 10.1016/j.jacc.2004.07.050</mixed-citation><mixed-citation xml:lang="en">Wolk R, Berger P, Lennon RJ, Brilakis ES, Johnson BD, Somers VK. Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol. 2004;44(9):1819-1824. doi: 10.1016/j.jacc.2004.07.050</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wallander M, Söderberg S, Norhammar A. Leptin: a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes. Diabet Med. 2008;25(8):949-955. doi: 10.1111/j.1464-5491.2008.02509.x</mixed-citation><mixed-citation xml:lang="en">Wallander M, Söderberg S, Norhammar A. Leptin: a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes. Diabet Med. 2008;25(8):949-955. doi: 10.1111/j.1464-5491.2008.02509.x</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ku IA, Farzaneh-Far R, Vittinghoff E, Zhang MH, Na B, Whooley MA. Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study. Atherosclerosis. 2011;217(2):503-508. doi: 10.1016/j.atherosclerosis.2010.10.047</mixed-citation><mixed-citation xml:lang="en">Ku IA, Farzaneh-Far R, Vittinghoff E, Zhang MH, Na B, Whooley MA. Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study. Atherosclerosis. 2011;217(2):503-508. doi: 10.1016/j.atherosclerosis.2010.10.047</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Холматова КК, Дворяшина ИВ, Супрядкина ТВ. Различные варианты нарушений углеводного обмена и их влияние на течение инфаркта миокарда у пациентов г. Архангельска. Экология человека. 2013;(10):14-22. [Kholmatova KK, Dvoryashina IV, Supryadkina TV. Razlichnye varianty narusheniy uglevodnogo obmena i ikh vliyanie na techenie infarkta miokarda u patsientov g. Arkhangel'ska. Human Ecology. 2013;(10):14-22.]</mixed-citation><mixed-citation xml:lang="en">Холматова КК, Дворяшина ИВ, Супрядкина ТВ. Различные варианты нарушений углеводного обмена и их влияние на течение инфаркта миокарда у пациентов г. Архангельска. Экология человека. 2013;(10):14-22. [Kholmatova KK, Dvoryashina IV, Supryadkina TV. Razlichnye varianty narusheniy uglevodnogo obmena i ikh vliyanie na techenie infarkta miokarda u patsientov g. Arkhangel'ska. Human Ecology. 2013;(10):14-22.]</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Супрядкина ТВ. Влияние гормонально-метаболических нарушений на результаты аортокоронарного шунтирования у больных с различными вариантами накопления и распределения жировой ткани. Автореф. дисс…канд. мед. наук. Архангельск; 2010. 24 с. [Supryadkina TV. Vliyanie gormonal'no-metabolicheskikh narusheniy na rezul'taty aortokoronarnogo shuntirovaniya u bol'nykh s razlichnymi variantami nakopleniya i raspredeleniya zhirovoy tkani. [dissertation] Arkhangelsk; 2010. 24 p.]</mixed-citation><mixed-citation xml:lang="en">Супрядкина ТВ. Влияние гормонально-метаболических нарушений на результаты аортокоронарного шунтирования у больных с различными вариантами накопления и распределения жировой ткани. Автореф. дисс…канд. мед. наук. Архангельск; 2010. 24 с. [Supryadkina TV. Vliyanie gormonal'no-metabolicheskikh narusheniy na rezul'taty aortokoronarnogo shuntirovaniya u bol'nykh s razlichnymi variantami nakopleniya i raspredeleniya zhirovoy tkani. [dissertation] Arkhangelsk; 2010. 24 p.]</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wahlqvist ML, Chuang SY. Paradoxes with weight disorders for health systems. Asia Pac J Clin Nutr. 2012;21(4):471-475. PMid:23017304</mixed-citation><mixed-citation xml:lang="en">Wahlqvist ML, Chuang SY. Paradoxes with weight disorders for health systems. Asia Pac J Clin Nutr. 2012;21(4):471-475. PMid:23017304</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Canavan B, Salem RO, Schurgin S, Koutkia P, Lipinska I, Laposata M, et al. Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation. J Clin Endocrinol Metab. 2005;90(10):5779-5785. doi: 10.1210/jc.2005-0780</mixed-citation><mixed-citation xml:lang="en">Canavan B, Salem RO, Schurgin S, Koutkia P, Lipinska I, Laposata M, et al. Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation. J Clin Endocrinol Metab. 2005;90(10):5779-5785. doi: 10.1210/jc.2005-0780</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
